Key facts
- Notable investors include AmA Invest.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Aifory
- ·The full record, as it builds
Funding rounds
No funding rounds for Aifory are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aifory
Manufacturer of cannabis diet supplement products intended for promoting health and wellness. The company offers a range of hemp-derived products such as oils, capsules, gummies, and sprays, enabling consumers to incorporate CBD into their wellness routines.
- Sector
- Healthcare
- HQ
- Poland
- Founded
- 2020
- Website
- aifory.com/
- Ownership
- Privately Held (backing)
Aifory doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aifory shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aifory in its N-PORT filings yet. We sweep new filings monthly.